<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gray BL</submitter><funding>Howard Hughes Medical Institute</funding><funding>NCI NIH HHS</funding><pagination>2621-4</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2652409</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(13)</volume><pubmed_abstract>Recognizing the value of including complex pyridines in small-molecule screening collections, we developed a previously unexplored [2 + 2 + 2]-cycloaddition of silyl-tethered diynes with nitriles. The tether provides high regioselectivity, while the solvent THF allows catalytic CpCo(CO)(2) to be used without exogenous irradiation. One of the resulting bicyclic and monocyclic (desilylated) pyridines was identified as an inhibitor of neuregulin-induced neurite outgrowth (EC(50) = 0.30 microM) in a screen that probes a pathway likely to be involved in breast cancers and schizophrenia.</pubmed_abstract><journal>Organic letters</journal><pubmed_title>Diversity synthesis of complex pyridines yields a probe of a neurotrophic signaling pathway.</pubmed_title><pmcid>PMC2652409</pmcid><funding_grant_id>P01 CA-078048</funding_grant_id><funding_grant_id>P01 CA078048</funding_grant_id><pubmed_authors>Schreiber SL</pubmed_authors><pubmed_authors>Gray BL</pubmed_authors><pubmed_authors>Kuai L</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Brown WC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diversity synthesis of complex pyridines yields a probe of a neurotrophic signaling pathway.</name><description>Recognizing the value of including complex pyridines in small-molecule screening collections, we developed a previously unexplored [2 + 2 + 2]-cycloaddition of silyl-tethered diynes with nitriles. The tether provides high regioselectivity, while the solvent THF allows catalytic CpCo(CO)(2) to be used without exogenous irradiation. One of the resulting bicyclic and monocyclic (desilylated) pyridines was identified as an inhibitor of neuregulin-induced neurite outgrowth (EC(50) = 0.30 microM) in a screen that probes a pathway likely to be involved in breast cancers and schizophrenia.</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Jul</publication><modification>2025-04-20T02:09:14.804Z</modification><creation>2019-03-27T00:21:06Z</creation></dates><accession>S-EPMC2652409</accession><cross_references><pubmed>18510333</pubmed><doi>10.1021/ol8004936</doi></cross_references></HashMap>